1. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
   Soumya R. Mohapatra et al, 2019, Frontiers in Immunology CrossRef
2. Hydroxyl safflower yellow A regulates the tumor immune microenvironment to produce an anticancer effect in a mouse model of hepatocellular carcinoma
   Yicong Ma et al, 2019, Oncology Letters CrossRef
3. The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
   Joanna Domagala et al, 2020, Cancers CrossRef
4. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
   Kamilla JA. Bigos et al, 2024, Frontiers in Oncology CrossRef
5. Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
   Yi Lin et al, 2022, Frontiers in Immunology CrossRef
6. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
   Thomas Kolben et al, 2022, Cellular Oncology CrossRef
7. Tumor metastasis: Mechanistic insights and therapeutic interventions
   Mengmeng Liu et al, 2021, MedComm CrossRef
8. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition
   Jinfeng Pan et al, 2017, International Journal of Oncology CrossRef
9. Preoperative globulin‐to‐albumin ratio predicts outcome after curative resection in patients with gastric cancer
   Takayuki Shimizu et al, 2018, Annals of Gastroenterological Surgery CrossRef
10. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
    Chunxiao Li et al, 2020, Molecular Cancer CrossRef
11. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
    Raefa Abou Khouzam et al, 2022, Frontiers in Immunology CrossRef